Diagnostic News and Research

RSS

Vanderbilt researchers study novel sound wave technology to diagnose sports concussions

Researchers at the Vanderbilt Sports Concussion Center are using novel sound wave technology as part of an attempt to more rapidly and accurately diagnose sports concussions on the sidelines during games.

29 Sep 2015

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Advanced smartphone-enabled medical device technology for the rapid and cost-effective detection of infectious diseases will be featured at this year’s prestigious Medica show.

29 Sep 2015

Real-time blood test based on DNA sequencing can rapidly diagnose Ebola and other acute infections

Using technical advances not yet developed when the 2014 Ebola outbreak began, UC San Francisco-led scientists completed a proof-of-principle study on a real-time blood test based on DNA sequencing that can be used to rapidly diagnose Ebola and other acute infections. The researchers said that the test can be used even where lab space and medical infrastructure are scarce.

From Oxford Nanopore Technologies 29 Sep 2015

Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples

Roche has announced the commercial availability in countries that accept the CE mark1 of the cobas® EGFR Mutation Test v2, the first oncology assay from Roche that utilises either plasma or tumour tissue as a sample. The test identifies 42 mutations in the epidermal growth factor receptor (EGFR) gene, the most of any In-vitro Diagnostic (IVD) on the market, and can also be used as an aid in selecting eligible patients with non-small cell lung cancer (NSCLC) for therapy with an EGFR tyrosine kinase inhibitor (TKI).

From Roche Sequencing and Life Science 28 Sep 2015

Genetic test identifies breast cancer patients that can avoid chemotherapy and remain relapse-free following five years of hormone therapy

Genomic Health has announced the presentation of the first results1 from the Trial Assigning IndividuaLised Options for Treatment (Rx), or TAILORx, a large, prospectively conducted trial designed and conducted by the ECOG-ACRIN Cancer Research Group under the sponsorship of the U.S. National Cancer Institute (NCI).

28 Sep 2015

Frequent infections in early life may increase risk factor for coeliac disease development in later life

Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.

28 Sep 2015

Arteries may be best source for detecting circulating tumor cells

As the field of liquid biopsies for tracking disease progression and therapeutic response heats up, many doctors are looking for ways to apply this approach to their patients.

26 Sep 2015

Creating a new paradigm for management of yeast infections

Yeasts are unicellular microorganisms classified within the Fungi kingdom. They are well known for their use in baking, winemaking and beer brewing fermentation, but some species of yeast are opportunistic pathogens that can cause infections in humans. "Today, yeast infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide.

26 Sep 2015

Lumbar puncture well-accepted by memory clinic patients

Researchers support the increasing use of lumbar punctures (LPs) by memory clinics to collect cerebrospinal fluid, as long as certain risk factors are taken into account.

25 Sep 2015

Scientists compile complete genetic information of people affected by PAH

The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.

25 Sep 2015

Researchers develop new blood test to diagnose coeliac disease

Diagnosis of coeliac disease requires a tissue sample from the small intestine, which can be extremely unpleasant. Researchers at the Faculty of Medicine have developed a blood test which provides a rapid, painless answer.

25 Sep 2015

CUMC's Laboratory of Personalized Genomic Medicine granted approval for Columbia Combined Cancer Panel

The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.

25 Sep 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF, announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham.

From EKF Diagnostics 24 Sep 2015

Florida Institute finalizes funding agreement with Aviana

The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with Aviana Molecular Technologies, an Orlando-based company with technology developed at the University of Central Florida.

24 Sep 2015

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 24 Sep 2015

Researchers to use big data to improve classification of mood disorders

Mood disorders like depression are common among U.S. adults. Still, such disorders remain challenging for clinicians to diagnose and treat effectively.

24 Sep 2015

Discovery opens door to more targeted, effective treatments for cancer

In a discovery that could lead to more targeted and effective treatments for certain lung and prostate cancers, researchers at the University of Virginia School of Medicine have identified two new cancer-causing gene mutations - mutations that may be particularly susceptible to cancer-fighting drugs already approved by the federal Food and Drug Administration. One of the gene mutations also may play a key role in early menopause.

24 Sep 2015

Researchers call on NICE, RCOG to update guidelines for diagnosing early miscarriage

Researchers are calling for improvements to the way early miscarriage is diagnosed following a new study published today in the BMJ.

24 Sep 2015

NGN3-expressing cells in adult human pancreas offer hope to diabetics

Cells that express neurogenin 3 (NGN3) may one day be harnessed to create a plentiful supply of insulin-producing beta cells for the treatment of diabetes, a study led by researchers at the University of South Florida suggests.

24 Sep 2015

NeoGenomics introduces new NeoSITE Cervical FISH assay

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, announced today an expansion of its comprehensive FISH (Fluorescence In Situ Hybridization) testing menu to include a new NeoSITE Cervical assay to provide additional diagnostic information on abnormal Pap smears.

23 Sep 2015

Diagnostic News and Research

Vanderbilt researchers study novel sound wave technology to diagnose sports concussions

OJ-Bio to showcase new smartphone-enabled diagnostic testing device at Medica 2015

Real-time blood test based on DNA sequencing can rapidly diagnose Ebola and other acute infections

Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples

Genetic test identifies breast cancer patients that can avoid chemotherapy and remain relapse-free following five years of hormone therapy

Frequent infections in early life may increase risk factor for coeliac disease development in later life

Arteries may be best source for detecting circulating tumor cells

Creating a new paradigm for management of yeast infections

Lumbar puncture well-accepted by memory clinic patients

Scientists compile complete genetic information of people affected by PAH

Researchers develop new blood test to diagnose coeliac disease

CUMC's Laboratory of Personalized Genomic Medicine granted approval for Columbia Combined Cancer Panel

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

Florida Institute finalizes funding agreement with Aviana

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

Researchers to use big data to improve classification of mood disorders

Discovery opens door to more targeted, effective treatments for cancer

Researchers call on NICE, RCOG to update guidelines for diagnosing early miscarriage

NGN3-expressing cells in adult human pancreas offer hope to diabetics

NeoGenomics introduces new NeoSITE Cervical FISH assay

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News